Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haoxi Health Technology Limited, a foreign private issuer, on April 22, 2026. The filing serves to furnish the Unaudited Condensed Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the six-month period ended December 31, 2025, alongside comparative data for the same period in 2024.
Key Financial Metrics
The provided text is a cover sheet and exhibit index; it does not contain the actual financial statements or MD&A content. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes or comparative analysis between the current and prior periods are detailed in the provided text, as the substantive financial data is contained in the referenced exhibits (99.1 and 99.2) rather than the cover document.
Guidance, Outlook, and Risks
The filing text does not include management commentary, future guidance, risk factors, contingencies, or unusual items. These disclosures are expected to be found within the attached Management's Discussion and Analysis exhibit.
Investor Verification Checklist
- Verify the actual financial performance by reviewing Exhibit 99.1 (Unaudited Condensed Consolidated Financial Statements).
- Review Exhibit 99.2 for management's explanation of results, liquidity analysis, and risk factors.
- Confirm the company's continued status as a foreign private issuer filing under Form 20-F.
- Check for any subsequent filings that may update the interim results for the six months ended December 31, 2025.